Presentation given by Manuel Pérez, from Imegen, in the framework of the Emergence Forum Barcelona Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation. More information at: http://www.b2match.eu/emergenceforum2014

1. 04-2014
Human Health Track
Instituto de Medicina Genómica

2. What is Imegen
Instituto de Medicina Genómica is a reference
laboratory that provides specialized products and
services in the field of Medical Genetics
Imegen was founded in 2009 as an spin-off of the
University of Valencia by two scientists with more that
16 years of entrepreneurial experience in genetics and
genomics

3. Mission & Objectives
Mission: To improve Human Health and the Quality of Life of
people by means of diagnostic, prognostic and preventive gene testing
services under high quality standards
Objectives: To provide high quality products and services for molecular
diagnosis of human disease by making use of our wide experience, continuous
investment in R+D, and strengthening alliances and collaborations with other
companies and research groups

4. Qué hacemos
- Gene Testing of
Human Disease
- CGX Arrays
- Diagnostic kits
- GMO Testing
- Allergen Detection
- Species
identification
- Kits of analysis
- Next Generation
Sequencing
- Transcriptomics
- Bioinformatics
- Non invasive
Prenatal Diagnosis
Human Health Food Safety Research

5. Human Health
• Reference Laboratory for gene testing
• One of the widest portfolios in Europe, more than 1,600 genetic diseases
• Diagnostic Services of clinical utility
• Customized designs for any genetic disease, 10-15 new developments per
month

6. Performing gene testing
1. DNA/RNA extraction (normally from blood)
2. Gene selection and amplification
3. DNA sequencing (or other methods)
4. Analysis of the results and reporting
Genetic diseases have a prevalence of ca.
6% in the population

7. R & D Clinical Genetics

8. Food Safety
• Acreditation ISO17025:2005
• Detection and quantification of more than 30 transgenic events
• Allergen detection
• Species Identification meat, vegetables, fish, bacteria, fungi
• Custom test design

9. Besides services, Imegen designs and
provide testing kits so qualified
customers can perform their own
assays
Imegen provides kits for human
health and the Agrofood industry
Packaging our know how

10. Imegen in numbers (2014)
3 M€ Annual turnover (last year)
30 employees (89% with the university degree)
15 countries (26% international sales)
3,900 samples tested in 2013
>1,600 gene tests available
3 new biotech companies incubated by Imegen
2 National research projects
2 European research Project